Guidelines are painted with broad strokes and cannot possibly cover complex situations that emerge in the care of people with chronic kidney disease and multiple illnesses. The authors of the recent KDIGO blood pressure guidelines should be congratulated on urging us to individualize therapy especially in situations where the evidence base is thin.
This is a preview of subscription content, log in via an institution to check access.
References
Becker, G. J. & Wheeler, D. C. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. Suppl. 2, 337–414 (2012).
National Institutes of Health National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [online], (2004).
Acknowledgements
The author's work is supported by the National Institutes of Health and the Department of Veterans Affairs.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares associations with the following companies: Abbott (speakers' bureau), Daiichi Sankyo (consultant, grant/research support), Merck (speakers' bureau), Takeda (consultant).
Rights and permissions
About this article
Cite this article
Agarwal, R. KDIGO BP guidelines—more individualized, less prescriptive. Nat Rev Nephrol 9, 131–133 (2013). https://doi.org/10.1038/nrneph.2013.16
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.16
- Springer Nature Limited